The global meningitis genome partnership

Area of Science:

• Microbiology
• Genomics
• Public Health

Background:

• Genomic surveillance of bacterial meningitis pathogens is critical for global disease control.
• Whole genome sequencing use is limited by country capacity and resources, particularly in high-burden low and middle-income countries.
• The Defeating Meningitis by 2030 Global Roadmap emphasizes expanding global surveillance capacity.

Purpose of the Study:

• To establish a Global Meningitis Genome Partnership to coordinate genomic surveillance of key bacterial meningitis pathogens.
• To link resources for tracking Neisseria meningitidis (Nm), Streptococcus pneumoniae (Sp), Haemophilus influenzae (Hi), and Streptococcus agalactiae (Sa).
• To improve worldwide coordination of strain identification and tracking for meningitis pathogens.

Main Methods:

• Leveraging existing genomic databases such as PubMLST, The Wellcome Sanger Institute, and BMGAP.
• Establishing a steering group to coordinate the initiative and ensure high-quality data curation.
• Developing guidelines for open-access genomic data sharing and defining core metadata.

Main Results:

• Multiple platforms (PubMLST, Wellcome Sanger Institute, BMGAP) host significant numbers of relevant bacterial genomes.
• A steering group is being formed to manage the Global Meningitis Genome Partnership.
• Guidelines for data sharing, metadata, and user-friendly interfaces are planned.

Conclusions:

• A coordinated global effort is needed to enhance genomic surveillance of bacterial meningitis.
• The Global Meningitis Genome Partnership aims to bridge resource gaps and improve global tracking of meningitis pathogens.
• Future work will focus on data standardization, open access, and accessible data representation.